Aldeyra Therapeutics Stock (NASDAQ: ALDX) stock price, news, charts, stock research, profile.
Open | $5.26 |
Close | $5.57 |
Volume / Avg. | 516.88K / 451.28K |
Day Range | $5.24 - $5.69 |
52 Wk Range | 1.42 - 7.81 |
Market Cap | $338.66M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 69 |
Short Interest | 5.19% |
Days to Cover | 9.57 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Aldeyra Therapeutics (NASDAQ:ALDX) through any online brokerage.
Other companies in Aldeyra Therapeutics’s space includes: Cabaletta Bio (NASDAQ:CABA), Precigen (NASDAQ:PGEN), Inozyme Pharma (NASDAQ:INZY), PepGen (NASDAQ:PEPG) and Adaptimmune Therapeutics (NASDAQ:ADAP).
Aldeyra Therapeutics has a consensus price target of $11.60.
The stock price for Aldeyra Therapeutics (NASDAQ: ALDX) is $5.7 last updated August 23, 2024 at 7:02 PM EDT.
There are no upcoming dividends for Aldeyra Therapeutics.
Aldeyra Therapeutics’s Q3 earnings are confirmed for Friday, November 1, 2024.
There is no upcoming split for Aldeyra Therapeutics.
Aldeyra Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.